Research at Oslo University Hospital

The University of Oslo has announced that Anders Jahre's major medical prize for 2022 of NOK 1 million goes to Harald Stenmark, head of the Cellular Membrane Dynamics research group at the Department of Molecular Biology at the Institute for Cancer Research.

Anders Jahre's medical awards reward outstanding research in basic and clinical medicine. The annual prizes are distributed by the University of Oslo and are among the largest in medicine in the Nordic countries.

The prizes for 2022 will be given out in the University's auditorium on Thursday 3 November at 18:00.

The postdoctoral programme courses at the Faculty of Medicine at UiO for the autumn of 2022 are now open for registration. 

The programme is a career development programme designed for researchers at the beginning of their career.

The following courses are offered:

• Career development (apply within 31st of July)
• Communicating research and writing grant applications (apply within 14th of August)
• Research management and supervision (apply within 18th of September)

They are also offering a peer mentoring scheme.

At the Digital Scholarship Centre (DSC) you get guidance on how you can make the best possible use of digital tools and methods in your research and communication activities.

Among the topics are Open Access, Research Data Management, Systematic search, Visualisation and Reference management.

The DSC runs a number of useful courses and workshops during the autumn of 2022 via Zoom. These are open for OUS employees.

The Innovative Health Initiative (IHI) - a public-private partnership (PPP) between the European Union and the European life science industries - has now launched IHI – calls 1 and 2.

IHI call 1 was launched on 28 June 2022 with topics on cancer, neurodegenerative diseases, and health data.
The deadline for full proposals is 20 September 2022.

IHI call 2 was launched 28 June 2022 with topics on cardiovascular disease and early feasibility studies.
The deadline for short proposals is 20 September 2022.

Oslo University Hospital (OUS) has implemented a new procedure to ensure good routines and efficient use of resources when it comes to inquiries from the industry about participation in clinical trials.

Clinical trials performed on behalf of the pharmaceutical or medical equipment industry is an important task for the hospital and a significant contribution to the development of the best possible treatment for our patients. Therefore, it is important that requests from the industry for participation in such trials reach the correct recipient in the hospital, and that all requests are assessed and answered as soon as possible and always within given deadlines.

Three Oslo University Hospital scientists received prestigous awards for their outstanding research on Friday June 10th. The major prize - the "Excellent Researcher Award" - went to Håvard Danielsen. Silje Fjellgård Jørgensen and Geir Ringstrøm both received the "Early Career Award".
The prize money - 300.000 and 150.000 NOK respectively - is earmarked for research activities.

The awards are distributed anually in order to honour excellent scientific work. The awarding process is organized by the hospital's research committee, while an external Scientific Advisory Board has evaluated the candidates. 

The South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF) announces approximately NOK 110 million for health research funding in the region.

For 2023, research funding can be applied for within the following application categories:
Doctoral scholarships, Postdoctoral fellowships and Open project support.

Application deadline is Tuesday, September 6th 2022 16:00.

Biodistribution, metabolism and excretion studies are important in order to obtain market approval of new products for medical imaging or therapeutic use.

In this review, senior scientists in the Sandvig group at the Department of Molecular Cell Biology, Institute for Cancer Research, discuss the possibilities and challenges with currently available methods with a focus on what is needed to bring such studies in small animals forward in an optimal way. 

The review is published in the prestigious journal Advanced Drug Delivery Research (IF 15.5).